MORGANTOWN, W.Va. – Surgeons at the WVU Heart and Vascular Institute are now offering a new minimally invasive treatment for patients with carotid artery disease.
The carotid arteries are the two large blood vessels in the neck that supply the brain and head with blood. Carotid artery disease occurs when the arteries become narrow or blocked as the result of a buildup of fatty plaque. This can cause small clots to form, and those clots can cause a stroke.
Currently, the most common treatments for severe carotid artery disease are carotid endarterectomy, an open surgical procedure, and transfemoral carotid angioplasty and stenting, a minimally invasive option for patients at high risk for stroke and other complications.
Surgeons at the WVU Heart and Vascular Institute are now performing transcarotid artery revascularization (TCAR) using the ENROUTE® Transcarotid Neuroprotection System, which is designed to reduce the risk of stroke while inserting the ENROUTE® Transcarotid Stent.
Read More: https://wvumedicine.org/news/article/wvu-heart-and-vascular-institute-offering-new-procedure-for-carotid-artery-disease/
Via: WVU Medicine Via: Endovascular Today Since its introduction in the 1950s, carotid endarterectomy (CEA) has been considered the gold standard treatment option for carotid revascularization. However, in patients with high-risk anatomic and/or physiologic characteristics, CEA is associated with higher rates of adverse outcomes.1 Transfemoral carotid angioplasty and stenting (TF-CAS) was introduced over 2 decades ago as a potential alternative. However, its effectiveness compared to CEA remains unclear, and full adoption of TF-CAS has been hindered by a higher rate of periprocedural stroke.2 Providing advanced medical care in a patient's home once required the help of trained professionals. No longer -- new sensor technology is enabling a massive migration from hospitals to home care environments. Quest, Omada Health Collaboration Shows One-Third in Workforce Study Reduced Risk for Diabetes6/27/2018
Via: AJMC A study presented Monday at the American Diabetes Association (ADA) Scientific Sessions found that one-third of those who initially screened positive for prediabetes or diabetes were able to bring their blood sugar down to normal levels after taking part in a workforce-based intervention. Via: FierceCEO When not researching systems to prevent strokes, you might find Silk Road Medical CEO Erica Rogers on the dance floor or acting in a staging of “The Sound of Music.” Via: PR Newswire Digital Therapeutics Pioneer Launches Comprehensive, Personalized Solution for Obesity-Related Chronic Disease Via: Healio Compared with carotid endarterectomy, transcarotid artery revascularization was associated with similar in-hospital outcomes in patients with carotid stenosis, according to data presented at the Society for Vascular Surgery Vascular Annual Meeting. Via: MobiHealthNews Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Silk Road Medical Announces Key Events for Society for Vascular Surgery 2018 Vascular Annual Meeting6/18/2018
Via: Business Wire SUNNYVALE, Calif.--(BUSINESS WIRE)--Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced key events at the upcoming Society for Vascular Surgery 2018 Vascular Annual Meeting (VAM) June 20-23 at the Hynes Convention Center in Boston. These include real-world data presentations comparing the company’s TransCarotid Artery Revascularization (TCAR) procedure to transfemoral carotid artery stenting (TFCAS) and carotid endarterectomy (CEA), as well as other company-sponsored events about TCAR. Via: OncoMed Expanded Phase of Trial will Assess anti-TIGIT in Combination with anti-PD1 |
Archives
October 2023
|